Resources

Our community of economists and academic leaders from around the United States are united in their belief that more competition, innovation, accountability, consumer choice, and transparency are needed in America’s healthcare sector to improve the health and well-being of every patient.

The Opaque Industry Secretly Inflating Prices for Prescription Drugs

June 21, 2024

Pharmacy benefit managers are driving up drug costs for millions of people, employers and the government.

New York Times

By Rebecca Robbins and Reed Abelson

Spending in the 340B Drug Pricing Program, 2010 to 2021

June 17, 2024

Congressional Budget Office

Presentation by Rebecca Sachs and Joshua Varcie, analysts in CBO’s Health Analysis Division, at the 13th Annual Conference of the American Society of Health Economists.

Federal Support Should Not Be A Factor In Determining Pharmaceutical Prices Under The IRA

June 14, 2024

Health Affairs

By Frederick McElwee, Amanda Cole, Louis P. Garrison, Jr., and Adrian Towse

Price Transparency in Health Care: The Consumer Opportunity

June 5, 2024

AEI Economic Perspectives

By James C. Capretta and Jack Rowing

Evaluating Pharmaceutical Policy Options

June 1, 2024

National Bureau of Economic Research

By Kate Ho and Ariel Pakes
NBER Working Paper No. 32606
Scroll to Top